8-K - Aprea Therapeutics, Inc. (0001781983) (Filer)
Published . Updated .
Key takeaways
- 8-K - Aprea Therapeutics filed an 8-K with the SEC on Nov 4 (a notice of a material company event).
- Exposed: APRE
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Aprea Therapeutics filed an 8-K with the SEC on Nov 4 (a notice of a material company event).
Directly affected
- APRE Aprea Therapeutics
Named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| APRE | +7.40% | +0.00% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-04 AccNo: 0001104659-26-122403 Size: 6 MB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How far Aprea Therapeutics (APRE) has moved since 4 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| Aprea Therapeutics (APRE) | three days earlier | 0.00% | final price |
| Aprea Therapeutics (APRE) | five days earlier | +7.40% | final price |
Who is named in “8-K - Aprea Therapeutics, Inc. (0001781983) (Filer)”
Companies tied to this story
- APRE Aprea Therapeutics
In “8-K - Aprea Therapeutics, Inc. (0001781983) (Filer),” Aprea Therapeutics (APRE) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> APRE
How “8-K - Aprea Therapeutics, Inc. (0001781983) (Filer)” reaches Aprea Therapeutics (APRE)
On 4 Nov 2026, “8-K - Aprea Therapeutics, Inc. (0001781983) (Filer)” is the story that connects Aprea Therapeutics (APRE) to this story.
The link for Aprea Therapeutics (APRE) is this: SEC 8-K filing -> direct issuer disclosure -> APRE
What the saved facts support for Aprea Therapeutics (APRE)
14 out of 100
“8-K - Aprea Therapeutics, Inc. (0001781983) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.